Casey Weaver recounts how his group’s discovery of the TH17 pathway resolved several conundrums that had arisen in the wake of the original TH1–TH2 hypothesis.
References
Mosmann, T. R., Cherwinski, H., Bond, M. W., Giedlin, M. A. & Coffman, R. L. J. Immunol. 136, 2348–2357 (1986).
Harrington, L. E. et al. Nat. Immunol. 6, 1123–1132 (2005).
Hsieh, C.-S., Heimberger, A. B., Gold, J. S., O'Garra, A. & Murphy, K. M. Proc. Natl Acad. Sci. USA 89, 6065–6069 (1992).
Hsieh, C.-S. et al. Science 260, 547–549 (1993).
Janeway, C. A. Jr. Cold Spring Harb. Symp. Quant. Biol. 54, 1–13 (1989).
Powrie, F. et al. Immunity 1, 553–562 (1994).
Oppmann, B. et al. Immunity 13, 715–725 (2000).
Cua, D. J. et al. Nature 421, 744–748 (2003).
Murphy, C. A. et al. J. Exp. Med. 198, 1951–1957 (2003).
Aggarwal, S., Ghilardi, N., Xie, M.-H., de Sauvage, F. J. & Gurney, A. L. J. Biol. Chem. 278, 1910–1914 (2003).
Bettelli, E. & Kuchroo, V. K. J. Exp. Med. 201, 169–171 (2005).
Park, H. et al. Nat. Immunol. 6, 1133–1141 (2005).
Mangan, P. R. et al. Nature 441, 231–234 (2006).
Bettelli, E. et al. Nature 441, 235–238 (2006).
Veldhoen, M., Hocking, R. J., Atkins, C. J., Locksley, R. M. & Stockinger, B. Immunity 24, 179–189 (2006).
Weaver, C. T., Harrington, L. E., Mangan, P. R., Gavrieli, M. & Murphy, K. M. Immunity 24, 677–688 (2006).
Ivanov, I. I. et al. Cell 126, 1121–1133 (2006).
Lee, Y. K. et al. Immunity 30, 92–107 (2009).
Harbour, S. N., Maynard, C. L., Zindl, C. L., Schoeb, T. R. & Weaver, C. T. Proc. Natl Acad. Sci. USA 112, 7061–7066 (2015).
Hirota, K. et al. Nat. Immunol. 12, 255–263 (2011).
Infante-Duarte, C., Horton, H. F., Byrne, M. C. & Kamradt, T. J. Immunol. 165, 6107–6115 (2000).
Ye, P. et al. J. Exp. Med. 194, 519–527 (2001).
Weaver, C. T. & Hatton, R. D. Nat. Rev. Immunol. 9, 883–889 (2009).
Acknowledgements
The author thanks others in his group as well as colleagues who have contributed much to the discoveries recounted in this article.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing interest.
Rights and permissions
About this article
Cite this article
Weaver, C.T. One road to the TH17 pathway: how TH1 led to TH17 (and vice versa), and first came last. Nat Immunol 21, 819–821 (2020). https://doi.org/10.1038/s41590-020-0715-4
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41590-020-0715-4
- Springer Nature America, Inc.
This article is cited by
-
The effects of low-dose IL-2 on Th17/Treg cell imbalance in primary biliary cholangitis mouse models
BMC Gastroenterology (2024)
-
Stat5−/− CD4+ T cells elicit anti-melanoma effect by CD4+ T cell remolding and Notch1 activation
Science China Life Sciences (2022)